Evidence map›Paper›PMID 21575576›Full record

ArticleBiophysical journal2011

The molecular basis for antimicrobial activity of pore-forming cyclic peptides.

Anna D Cirac, Gemma Moiset, Jacek T Mika, Armagan Koçer, Pedro Salvador, Bert Poolman, Siewert J Marrink, Durba Sengupta

Abstract read
In one paragraph

Article in Biophysical journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. No Chance to Survive:Antibiotics (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cyclization Improves Membrane Permeation by Antimicrobial Peptoids.Langmuir : the ACS journal of surfaces and colloids · 2016
    Article
  16. Article
  17. Article
  18. Functional truncated membrane pores.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna D CiracDepartment of Biochemistry and Biophysical Chemistry, Groningen Biomolecular Sciences, Netherlands.
Gemma Moiset
Jacek T Mika
Armagan Koçer
Pedro Salvador
Bert Poolman
Siewert J Marrink
Durba Sengupta

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

The mechanism of action of antimicrobial peptides is, to our knowledge, still poorly understood. To probe the biophysical characteristics that confer activity, we present here a molecular-dynamics and biophysical study of a cyclic antimicrobial peptide and its inactive linear analog. In the simulations, the cyclic peptide caused large perturbations in the bilayer and cooperatively opened a disordered toroidal pore, 1-2 nm in diameter. Electrophysiology measurements confirm discrete poration events of comparable size. We also show that lysine residues aligning parallel to each other in the cyclic but not linear peptide are crucial for function. By employing dual-color fluorescence burst analysis, we show that both peptides are able to fuse/aggregate liposomes but only the cyclic peptide is able to porate them. The results provide detailed insight on the molecular basis of activity of cyclic antimicrobial peptides.

Indexed as

Amino Acid SequenceAnti-Infective AgentsComputational BiologyElectrophysiological PhenomenaFluorescenceLipid BilayersLiposomesMolecular Sequence DataPeptides, CyclicPhosphatidylglycerolsPorosityProtein Structure, SecondaryStructure-Activity Relationship1,2-dipalmitoylphosphatidylglycerolAnti-Infective AgentsLipid BilayersLiposomesPeptides, CyclicPhosphatidylglycerols

Identifiers

PMID21575576
PMCPMC3093570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.